Erratum: Results of a 5-Year Multicenter Trial of a New Generation Cooled High Energy Transurethral Microwave Thermal Therapy Catheter for Benign Prostatic Hyperplasia (The Journal of Urology (2011) 185(5) (1804–1810) (S0022534710053966) (10.1016/j.juro.2010.12.054));Results of a 5-year multicenter trial of a new generation cooled high energy transurethral microwave thermal therapy catheter for benign prostatic hyperplasia

Journal of Urology

Volumn 185, Issue 5, 2011, Pages 1804-1810

  Mynderse, Lance A ^a   Roehrborn, Claus G ^b   Partin, Alan W ^c   Preminger, Glenn M ^d   Coté, Eric P ^e  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c JOHNS HOPKINS HOSPITAL   (United States)

^d DUKE UNIVERSITY   (United States)

^e Virginia Urology Center   (United States)

Author keywords

catheterization; hyperthermia, induced; microwaves; prostate; prostatic hyperplasia

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADULT; AGED; ARTICLE; BENIGN PROSTATIC HYPERPLASIA IMPACT INDEX; BLADDER CATHETERIZATION; HOLMIUM LASER; HUMAN; INTERMITTENT CATHETERIZATION; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PATIENT SAFETY; PATIENT SATISFACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE HYPERTROPHY; PROSTATECTOMY; QUALITY OF LIFE; RETREATMENT; SURGICAL EQUIPMENT; SYMPTOM PROBLEM INDEX; TRANSURETHRAL MICROWAVE THERMOTHERAPY; TRANSURETHRAL RESECTION; TREATMENT DURATION; TREATMENT OUTCOME; UNITED STATES; URINE RETENTION; UROFLOWMETRY;

EID: 79953788658     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2011.05.003     Document Type: Erratum

References (22)

1. M.L. Blute, and R.W. Lewis Local microwave hyperthermia as a treatment alternative for benign prostatic hyperplasia J Androl 12 1991 429
2. PMAPremarket Approval United States Department of Health and Human Services, United States Food and Drug Administration http://www.accessdata.fda. gov/scripts/cdrh/cfdocs/cfPMA/pma.cfm?id=12543 Accessed July 15, 2010
3. T.R. Larson, M.L. Blute, and R.C. Bruskewitz A high-efficiency microwave thermoablation system for the treatment of benign prostatic hyperplasia: results of a randomized, sham-controlled, prospective, double-blind, multicenter clinical trial Urology 51 1998 731
4. Targis System Instruction for Use and User Manual. Minneapolis: Urologix 2010.
5. C.G. Roehrborn, G. Preminger, and P. Newhall Microwave thermotherapy for benign prostatic hyperplasia with the Dornier Urowave: results of a randomized, double-blind, sham-controlled trial Urology 51 1998 19
6. L. Wagrell, S. Schelin, and J. Nordling Feedback microwave versus TURP for clinical BPHa randomized controlled multicenter study Urology 60 2002 292
7. J. Krough, F. Hansen, and J. Nordling Transurethral microwave thermotherapy for the treatment of benign prostatic hyperplasia: results obtained with the Prostalund device World J Urol 16 1998 115
8. B. Djavan, C. Seitz, and C.G. Roehrborn Targeted transurethral microwave thermotherapy versus alpha-blockade in benign prostatic hyperplasia: outcomes at 18 months Urology 57 2001 66
9. M.P. Laguna, R. Muschter, and F.M.J. Debruyne Microwave thermotherapy: historical overview J Endourol 14 2000 603
10. C.G. Roehrborn, M. Blute, and A. Partin Long term efficacy of a 28.5-minute cooled thermotherapy (TUMT) treatment compared with 60-minute treatment for benign prostatic hyperplasia abstract J Urol 167 suppl. 2002 291
11. M.J. Barry, F.J. Fowler Jr, and M.P. O'Leary The American Urological Association symptom index for benign prostatic hyperplasia J Urol 148 1992 1549
12. Bosch R, Donovan J., et al. Symptom evaluation, quality of life and sexuality. In: Proceedings of the Second International Consultation of Benign Prostatic Hyperplasia (BPH). Edited by ATK Crockett, S Khoury, Y Aso et al. Jersey, Channel Islands: Scientific Communication International 1993; vol 2, chapt 5, pp 129147.
13. M.J. Barry, F.J. Fowler Jr, and M.P. O'Leary Measuring disease-specific health status in men with benign prostatic hyperplasia Med Care 33 1995 AS145
14. Y. Osman, B. Wadie, and T. El-Diasty High-energy transurethral microwave thermotherapy: symptomatic vs. urodynamic success BJU Int 91 2003 365
15. C. Huidobro, M. Bolmsjo, and T. Larson Evaluation of microwave thermotherapy with histopathology, magnetic resonance imaging and temperature mapping J Urol 171 2004 672
16. C.G. Roehrborn, P. Siami, and J. Barkin The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study Eur Urol 57 2010 123
17. J.D. McConnell, C.G. Roehrborn, and O.M. Bautista The long term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia N Engl J Med 349 2003 2387
18. C.G. Roerhborn Current medical therapies for men with lower urinary tract symptoms and benign prostatic hyperplasia: achievements and limitations Rev Urol 10 2008 14
19. A. Mattiasson, L. Wagrell, and S. Schelin Five-year follow-up of feedback microwave thermotherapy versus TURP for clinical BPH: a prospective randomized multicenter study Urology 69 2007 91
20. M.J. Barry, W.O. Williford, and Y. Chang Benign prostatic hyperplasia specific health status measure in clinical research: how much change in the American Urological Association symptom index and the benign prostatic hyperplasia impact index is perceptible to patients? J Urol 154 1995 1770
21. R.M. Hoffman, M. Monga, and S.P. Elliott Microwave thermotherapy for benign prostatic hyperplasia Cochrane Database Syst Rev 4 2007 CD004135
22. R. Webber Benign prostatic hyperplasia BMJ Clin Evid 4 2006 1801